EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

SKP2 in Cancer: From Molecular Regulation to Therapeutic Vulnerabilities and Translational Perspectives

Sheng-An Zheng iD, Cheng Wang iD, Xiao-Die Yao, Jia-Jia Sheng, Po-Wu Liu, Ying Wang, Shi-Jia Deng, He Li

Drug Design, Development and Therapy · 2026-08 · Volume 20 · 1-24

DOI: 10.2147/dddt.s619670 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-08. Verfasst von Sheng-An Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Investigation, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Chan…. Hauptthemen laut MEDLINE: S-Phase Kinase-Associated Proteins, Neoplasms, Antineoplastic Agents. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

S-Phase Kinase-Associated ProteinsNeoplasmsAntineoplastic AgentsHumansAnimalsMolecular Targeted Therapy

Stichwörter der Autor:innen

SKP2cancerdegradationdrug resistancetreatmentubiquitination

Substanzen

S-Phase Kinase-Associated ProteinsSKP2 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Center for Clinical Investigation, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, 410013, People's Republic of China.
  • School of Pharmacy, Dali University, Dali, Yunnan, 671000, People's Republic of China.
  • Department of Preventive Medicine, Medical School, Hunan University of Chinese Medicine, Changsha, Hunan, 410208, People's Republic of China.
  • Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, The "Double-First Class" Application Characteristic Discipline of Hunan Province (Pharmaceutical Science), Changsha M…

ORCID-Profile: Sheng-An Zheng, Cheng Wang

Zitieren

APA

Zheng, S. A., Wang, C., Yao, X. D., Sheng, J. J., Liu, P. W., Wang, Y., Deng, S. J., & Li, H. (2026). SKP2 in Cancer: From Molecular Regulation to Therapeutic Vulnerabilities and Translational Perspectives. Drug Design, Development and Therapy, Volume 20, 1-24. https://doi.org/10.2147/dddt.s619670

Vancouver

Zheng SA, Wang C, Yao XD, Sheng JJ, Liu PW, Wang Y, et al. SKP2 in Cancer: From Molecular Regulation to Therapeutic Vulnerabilities and Translational Perspectives. Drug Design, Development and Therapy. 2026;Volume 20:1-24. doi:10.2147/dddt.s619670

BibTeX
@article{Zheng2026,
  author = {Zheng, Sheng-An and Wang, Cheng and Yao, Xiao-Die and Sheng, Jia-Jia and Liu, Po-Wu and Wang, Ying and Deng, Shi-Jia and Li, He},
  title = {SKP2 in Cancer: From Molecular Regulation to Therapeutic Vulnerabilities and Translational Perspectives},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--24},
  doi = {10.2147/dddt.s619670}
}
Kostenlos starten →